19.18
前日終値:
$19.40
開ける:
$19.45
24時間の取引高:
35,765
Relative Volume:
0.51
時価総額:
$931.20M
収益:
-
当期純損益:
$-75.28M
株価収益率:
-9.6107
EPS:
-1.9957
ネットキャッシュフロー:
$-57.45M
1週間 パフォーマンス:
-1.99%
1か月 パフォーマンス:
-2.54%
6か月 パフォーマンス:
+55.79%
1年 パフォーマンス:
+59.17%
Oculis Holding Ag Stock (OCS) Company Profile
OCS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
OCS
Oculis Holding Ag
|
19.18 | 931.20M | 0 | -75.28M | -57.45M | -1.9957 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-12-05 | 開始されました | Chardan Capital Markets | Buy |
2023-10-05 | 開始されました | Stifel | Buy |
2023-06-14 | 開始されました | BofA Securities | Buy |
2023-06-12 | 開始されました | H.C. Wainwright | Buy |
2023-06-08 | 開始されました | Robert W. Baird | Outperform |
2023-05-10 | 開始されました | Pareto | Buy |
2023-04-28 | 開始されました | Wedbush | Outperform |
すべてを表示
Oculis Holding Ag (OCS) 最新ニュース
Oculis Holding AG (NASDAQ:OCS) Short Interest Down 14.1% in February - Defense World
Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities - Marketscreener.com
Insider Buying: Oculis Holding Independent Director Bought CHF326k Of Shares - Simply Wall St
Lionel Carnot Spends CHF326k On Oculis Holding Stock - Yahoo Canada Finance
HC Wainwright Comments on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World
Robert W. Baird Boosts Oculis (NASDAQ:OCS) Price Target to $41.00 - Defense World
HC Wainwright Lowers Oculis (NASDAQ:OCS) Price Target to $29.00 - Defense World
Oculis (NASDAQ:OCS) Sees Strong Trading Volume After Analyst Upgrade - Defense World
Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update - Informazione.it
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - Marketscreener.com
(OCS) Investment Analysis - Stock Traders Daily
Oculis Holding AG (OCS) Reports Q4 Loss, Misses Revenue Estimates - MSN
Stifel maintains Buy on Oculis shares, price target at $35 By Investing.com - Investing.com Australia
H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating - Investing.com Australia
H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating By Investing.com - Investing.com South Africa
Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions - TipRanks
Oculis price target raised to $32 from $31 at BofA - TipRanks
Oculis (NASDAQ:OCS) Shares Gap Down Following Weak Earnings - Defense World
Oculis Holding AG Reports 2024 Financial Results - TipRanks
Oculis Reports 2024 Fourth Quarter Net Loss, Completes $100 Million Equity Financing to Support Pipeline - Vision Monday
Stifel maintains Buy on Oculis shares, price target at $35 - Investing.com
Oculis Holding AG reports results for the quarter ended December 31Earnings Summary - TradingView
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress - TipRanks
Oculis (OCS) Projected to Post Quarterly Earnings on Monday - Defense World
(OCSAW) On The My Stocks Page - Stock Traders Daily
Oculis to Present at Upcoming March Investor Conference - The Manila Times
(OCS) Investment Report - Stock Traders Daily
(OCS) On The My Stocks Page - Stock Traders Daily
Oculis Holding AG (NASDAQ:OCS) Short Interest Down 68.6% in January - MarketBeat
Oculis (NASDAQ:OCS) Shares Down 7.2%Should You Sell? - MarketBeat
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering - TipRanks
Oculis Holding Prices Offering of 5 Million Shares -February 14, 2025 at 04:36 am EST - Marketscreener.com
Biopharmaceutical Company Oculis Seeks $100 Million from Share Sale -February 14, 2025 at 12:56 am EST - Marketscreener.com
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares - The Manila Times
Major Funding Breakthrough: Oculis Secures $100M for Revolutionary Eye Treatment Development - StockTitan
Oculis Raises Massive $100M War Chest: Major Pipeline Expansion for Revolutionary Eye Treatment - StockTitan
Oculis greinir frá umframeftirspurn og öðrum niðurstöðum 100 milljón USD útboðs á almennum hlutum - GlobeNewswire Inc.
Institutions along with retail investors who hold considerable shares inOculis Holding AG (NASDAQ:OCS) come under pressure; lose 8.9% of holdings value - Simply Wall St
(OCS) Trading Report - Stock Traders Daily
abrdn plc Buys 188,871 Shares of Oculis Holding AG (NASDAQ:OCS) - MarketBeat
Oculis (NASDAQ:OCS) Trading Down 0.2%Time to Sell? - MarketBeat
Insider Alert: Oculis Leadership Team Hits Major Share Vesting Milestone - StockTitan
Oculis (NASDAQ:OCS) Shares Down 0.2% – Time to Sell? - Defense World
Oculis Holding Ag (OCS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):